FSTL3 is a Prognostic Biomarker in Gastric Cancer and is Correlated with M2 Macrophage Infiltration
Yuan-Jie Liu,Jie-Pin Li,Ying Zhang,Meng-Jun Nie,Yong-Hua Zhang,Shen-Lin Liu,Xi Zou
DOI: https://doi.org/10.2147/ott.s314561
IF: 4
2021-07-01
OncoTargets and Therapy
Abstract:PURPOSE: Follistatin-related gene 3 (<i>FSTL3</i>), an established oncogene, can modulate target gene expression via members of the transforming growth factor β (TGF-β) superfamily. The present study was conducted to evaluate the expression of <i>FSTL3</i> in gastric cancer (GC) and to determine its prognostic significance. We also evaluated the possible mechanisms involved in the oncogenic role of <i>FSTL3</i> in gastric carcinogenesis and development.METHODS: We obtained data from the Human Protein Atlas, MethSurv, cBioPortal, UALCAN, TIMER, GEPIA, STRING, GeneMANIA, ONCOMINE, and MEXPRESS databases and examined it using R software. RNAi was used to establish stable <i>FSTL3</i>-knockdown (shFSTL3) and overexpression (OE) cell strains. Western blot; enzyme-linked immunosorbent (ELISA); and immunohistochemical (ICH), immunofluorescence, and phalloidin staining were used for examining protein expression. Cell invasion and migration were determined using transwell and scratch-wound assays. After tumor-associated macrophage (TAM) generation, co-culturing of cancer cells with TAMs was performed to confirm the relationship between <i>FSTL3</i> and TAMs.RESULTS: In GC patients, <i>FSTL3</i> mRNA and protein levels were upregulated. <i>FSTL3</i> expression was significantly linked to cancer stage as well as to pathological tumor grade in GC. Moreover, a high expression of <i>FSTL3</i> was associated with a dismal survival duration in patients with GC. Furthermore, functional enrichment analysis demonstrated that <i>FSTL3</i> overexpression could activate epithelial-mesenchymal transition (EMT) by promoting F-actin expression and BMP/SMAD signaling. Finally, immunofluorescence staining confirmed that the overexpression of FSTL3 promoted the proliferation of M2 TAMs.CONCLUSION: Taken together, our findings suggest that <i>FSTL3</i> may be involved in GC progression via the promotion of BMP/SMAD signaling-mediated EMT and M2 macrophage activation.
oncology,biotechnology & applied microbiology